The Saudi National Institute of Health was established to oversee and support transitional research and clinical trials in the field of health and aims to contribute to improving the health, well-being and quality of life of society, fund transitional research and clinical trials in the field of health and ensure the quality and efficiency of its outputs and transform the results of such research into health and economic benefits, including its investment in coordination with the relevant authorities. The Saudi NIH also aims to contribute to the consolidation of the efforts of stakeholders in transitional research and clinical trials.
Saudi Arabia Pavilion
Saudi Arabia is boldly shaping the future of biotechnology with unmatched ambition. Guided by its National Biotech Strategy launched in 2024, the Kingdom aims to become a leading global biotech hub by 2040 – focusing on developing a thriving, innovation focused sector contributing up to 3% of the country’s GDP. As part of Vision 2030, Saudi Arabia’s healthcare system is undergoing a systemic transformation to become more integrated, effective, and future-ready. The Kingdom has made – and will continue to make significant investments in world-class research institutions and cutting-edge infrastructure to power the biotech sector’s growth. In addition to its strong foundation, Saudi Arabia boasts a sophisticated and mature regulatory framework for red/medical biotech. This is underscored by its recognition from the WHO, which awarded the SFDA Maturity Level Four (ML4) for medicines and vaccines regulation – the highest level in the WHO’s classification of regulatory authorities for medical products. These advancements are further reinforced by growing private sector participation, including strategic partnerships with leading research institutions and substantial investments in expanding the Kingdom’s biomanufacturing capabilities Saudi Arabia’s strategic geographic location connects major emerging markets with a business-friendly environment and a fast and agile decision making to allow for speedy approvals. The Kingdom is a regional leader in genomic R&D, backed by advanced large-scale sequencing infrastructure, strong academic engagement, and impactful research – evidenced by over 100 published papers from the Saudi Human Genome Program since 2014 and a growing network of ~90 genomics researchers. In parallel, Saudi Arabia has invested several billion dollars in digital health infrastructure, building centralized health data platforms that support telemedicine, mobile health, remote monitoring, AI applications, and other cutting-edge digital health solutions. Join us at the KSA Pavilion to explore Saudi Arabia’s rapidly evolving biotech ecosystem. Discover the Kingdom’s livability, regulatory and funding landscape, connect with leading research institutions, and engage with key organizations driving KSA’s biotech frontier.
Saudi Commission for Health Specialties
The Saudi Commission for Health Specialties (SCFHS) was established in 1992 as a scientific professional body to regulate the work of health practitioners. It undertakes the tasks of documenting and evaluating the qualifications and experience of health practitioners, in addition to registering and classifying them to practice health professions in the Kingdom of Saudi Arabia. The SCFHS also supervises the Saudi Board Certification programs for health training in all health specialties, approves training centers, and issues Saudi Board certificates. The SCFHS also supervises the improvement of the level and efficiency of health workers by approving centers and programs for continuing education and professional development, in addition to approving the establishment of specialized scientific health associations and supervising them.
Saudi Entertainment & Amusement (SEA) Expo
Running for over 8 years in Riyadh, the Saudi Entertainment and Amusement (SEA) Expo brings together professionals from the world of entertainment and attractions under one roof, creating a unique global experience for like-minded individuals to connect. By collaborating, we can effectively address real-industry challenges and devise actionable solutions, ultimately sparking inspiration.
Saudi Entertainment and Amusement Expo
The Saudi Entertainment and Amusement (SEA) Expo, taking place 4 – 6 May 2026 at Riyadh Front, brings together professionals from the world of entertainment and attractions under one roof, creating a unique global experience for like-minded individuals to connect. By collaborating, we can effectively address real-industry challenges and devise actionable solutions, ultimately sparking inspiration.
Saudi Food and Drug Authority
The Saudi Food and Drug Authority (SFDA) is a regulatory body in Saudi Arabia responsible for ensuring the safety and efficacy of food, drugs, medical devices, and cosmetics. Established in 2003, it operates under the country’s Ministry of Health to: – Regulate and supervise food, pharmaceutical, and medical products. – Approve and monitor drugs, vaccines, and biologics. – Ensure compliance with local and international safety standards. – Conduct inspections and enforce regulations to protect public health. SFDA plays a key role in aligning Saudi Arabia’s health and food safety standards with global best practices, such as those of the FDA (USA) and EMA (Europe).
Saudi Health Council
National Cancer center of Saudi Arabia